Giraldi Laura, Lauridsen Emma Kofoed, Maier Andrea Daniela, Hansen Jørgen Vinsløv, Broholm Helle, Fugleholm Kåre, Scheie David, Munch Tina Nørgaard
Department of Epidemiology Research, Statens Serum Institute, DK-2300 Copenhagen, Denmark.
Department of Neurosurgery, Copenhagen University Hospital, DK-2100 Copenhagen, Denmark.
Cancers (Basel). 2021 Aug 1;13(15):3879. doi: 10.3390/cancers13153879.
Meningiomas are the most common intracranial tumor. During pregnancy, explosive growth of a known meningioma occasionally occurs, but the underlying reasons remain unknown. Prolactin has been suggested as a possible key contributor to pregnancy-related meningioma growth. This study sets out to investigate prolactin and prolactin receptor status in 29 patients with pregnancy-related meningiomas in Denmark, from January 1972 to December 2016, as compared to 68 controls aged 20-45 years, also undergoing resection of a meningioma. Furthermore, we investigated potential differences in the progesterone and estrogen receptor statuses, WHO grade, Ki-67 labeling indices, and locations of the resected meningiomas between the cases and controls. Immunohistochemical analyses were performed, and histopathology and intracranial location were assessed with the investigator blinded for the case-control status. None of the samples stained positive for prolactin and very few samples stained positive for prolactin receptors, equally distributed among cases and controls. Estrogen and progesterone receptors generally followed the same distributional pattern between groups, whereas above cut-point Ki-67 labeling indices for both groups were observed. In conclusion, our results did not support the notion of prolactin as a key contributor to pregnancy-related meningioma growth. Rather, the similarities between the cases and controls suggest that meningiomas early in life may comprise a distinct biological entity.
脑膜瘤是最常见的颅内肿瘤。在孕期,已知的脑膜瘤偶尔会出现快速生长,但潜在原因仍不明。催乳素被认为可能是孕期相关脑膜瘤生长的关键因素。本研究旨在调查1972年1月至2016年12月期间丹麦29例孕期相关脑膜瘤患者的催乳素及催乳素受体状态,并与68例年龄在20 - 45岁、同样接受脑膜瘤切除术的对照者进行比较。此外,我们还研究了病例组和对照组之间切除的脑膜瘤在孕激素和雌激素受体状态、世界卫生组织(WHO)分级、Ki-67标记指数及位置方面的潜在差异。进行了免疫组织化学分析,在不知道病例对照状态的情况下,由研究者评估组织病理学和颅内位置。没有样本催乳素染色呈阳性,催乳素受体染色呈阳性的样本很少,且在病例组和对照组中分布均匀。雌激素和孕激素受体在两组间通常遵循相同的分布模式,而两组均观察到高于切点的Ki-67标记指数。总之,我们的结果不支持催乳素是孕期相关脑膜瘤生长关键因素这一观点。相反,病例组和对照组之间的相似性表明,早期的脑膜瘤可能构成一个独特的生物学实体。